BofA Securities analyst Ronald J. Epstein reiterated the Neutral rating on Boeing Company (NYSE:BA) on Thursday, with a price forecast of $185.
The analyst states that Boeing still faces major hurdles in its turnaround efforts.
Key among them is the need to stabilize 737 model production at 38 units per month before seeking FAA approval to increase output to 42. Additionally, Epstein remarks that the company must keep its loss-making defense programs on track to avoid further pressure on free cash flow. Another concern is the ongoing impact of the tariff war, which could mean higher costs and continued delays in orders from China.
Also Read: Boeing Turns In Solid Q1, But Analyst Flags Ongoing Delivery Hurdles
The analyst views Boeing's recent award of the F-47 NGAD program by the White House and Air Force as a major strategic victory, especially under the leadership of new CEO Kelly Ortberg.
The contract is seen as a critical long-term opportunity that could strengthen Boeing's position in defense for decades.
While the R&D phase of the project has now been factored into their forecasts, the analyst remains mindful of potential "execution" risks.
Reflecting this new program and added interest income, Epstein raised the earnings per share estimates across the board—boosting the 2025 forecast to $0.35 from $0.15, the 2026 estimate to $3.90 from $2.55, and the 2027 projection to $5.85 from $4.90.
The analyst has revised the free cash flow outlook for Boeing, now anticipating a lower cash usage of $3.6 billion in 2025 compared to the earlier estimate of $4.5 billion.
Price Action: BA shares are trading higher by 2.72% to $177.11 at last check Thursday.
Read Next:
Photo by BlueBarronPhoto via Shutterstock
UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.
Get the latest stock analysis from Benzinga?
This article Boeing Faces Key Turnaround Challenges With Tariff Risks, China Orders: Analyst originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。